Organization profile

Organization profile

The Division of Arthritis and Rheumatic Diseases at Oregon Health & Science University is a group of academic physicians, allied health professionals and nurse practitioners specializing in the diagnosis and treatment of the full spectrum of rheumatic disorders.

Fingerprint Dive into the research topics where Arthritis & Rheumatic Diseases is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

Ankylosing Spondylitis Medicine & Life Sciences
Psoriatic Arthritis Medicine & Life Sciences
Rheumatoid Arthritis Medicine & Life Sciences
Placebos Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Tumor Necrosis Factor-alpha Medicine & Life Sciences
Inflammation Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Profiles

No photo of Mark Asquith

Mark Asquith

Person: Academic

20102019
No photo of Michael Davey
19812018

Projects 1978 2019

Hyaline Cartilage
Mesenchymal Stromal Cells
Cartilage
Regeneration
Bone Marrow
Experimental Arthritis
Interleukin-17
Interferons
Th17 Cells
Arthritis

Research Output 1991 2019

2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis

Ward, M. M., Deodhar, A. A., Gensler, L. S., Dubreuil, M., Yu, D., Khan, M. A., Haroon, N., Borenstein, D., Wang, R., Biehl, A., Fang, M. A., Louie, G., Majithia, V., Ng, B., Bigham, R., Pianin, M., Shah, A. A., Sullivan, N., Turgunbaev, M., Oristaglio, J. & 3 others, Turner, A., Maksymowych, W. P. & Caplan, L., Jan 1 2019, (Accepted/In press) In : Arthritis and Rheumatology.

Research output: Contribution to journalArticle

Spondylitis
LY2439821
Ankylosing Spondylitis
Tumor Necrosis Factor-alpha
Research

2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis

Ward, M. M., Deodhar, A. A., Gensler, L. S., Dubreuil, M., Yu, D., Khan, M. A., Haroon, N., Borenstein, D., Wang, R., Biehl, A., Fang, M. A., Louie, G., Majithia, V., Ng, B., Bigham, R., Pianin, M., Shah, A. A., Sullivan, N., Turgunbaev, M., Oristaglio, J. & 3 others, Turner, A., Maksymowych, W. P. & Caplan, L., Jan 1 2019, (Accepted/In press) In : Arthritis Care and Research.

Research output: Contribution to journalArticle

Spondylitis
LY2439821
Ankylosing Spondylitis
Tumor Necrosis Factor-alpha
Research

A Fifty-Two–Week, Randomized, Placebo-Controlled Trial of Certolizumab Pegol in Nonradiographic Axial Spondyloarthritis

Deodhar, A. A., Gensler, L. S., Kay, J., Maksymowych, W. P., Haroon, N., Landewé, R., Rudwaleit, M., Hall, S., Bauer, L., Hoepken, B., de Peyrecave, N., Kilgallen, B. & van der Heijde, D., Jul 1 2019, In : Arthritis and Rheumatology. 71, 7, p. 1101-1111 11 p.

Research output: Contribution to journalArticle

Open Access
Randomized Controlled Trials
Placebos
Ankylosing Spondylitis
Certolizumab Pegol
Therapeutics